Hari; Anitha

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hari; Anitha.The latest application filed is for "bisphenol a-free crosslinked polymer composition".

Company Profile

1.14.15

Hari; Anitha - Sausalito CA
Hari; Anitha - High Point NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Metal complexes and methods of treatment Grant 11,266,686 - Warner , et al. March 8, 2	2022-03-08
Bisphenol A-Free Crosslinked Polymer Composition App 20200181317 - Warner; John C. ; et al.	2020-06-11
Piperidine derivative and methods of use thereof Grant 10,364,233 - Mjalli , et al.	2019-07-30
Piperidine Derivative and Methods of Use Thereof App 20180362505 - Mjalli; Adnan M.M. ; et al.	2018-12-20
Metal Complexes and Methods of Treatment App 20160271175 - Warner; John C. ; et al.	2016-09-22
Phenyl-heteroaryl derivatives and methods of use thereof Grant 9,045,461 - Gohimukkula , et al. June 2, 2	2015-06-02
Phenyl-Heteroaryl Derivatives and Methods of Use Thereof App 20140206660 - Gohimukkula; Devi R. ; et al.	2014-07-24
Phenyl-heteroaryl derivatives and methods of use thereof Grant 8,741,900 - Gohimukkula , et al. June 3, 2	2014-06-03
Phenyl-Heteroaryl Derivatives and Methods of Use Thereof App 20130197007 - Gohimukkula; Devi R. ; et al.	2013-08-01
Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as .beta.-secretase inhibitors Grant 8,450,354 - Mjalli , et al. May 28, 2	2013-05-28
Phenyl-heteroaryl derivatives and methods of use thereof Grant 8,431,575 - Gohimukkula , et al. April 30, 2	2013-04-30
Crystalline forms of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)- -propyl]-diethyl-amine Grant 8,372,988 - Hari February 12, 2	2013-02-12
Substituted Imidazo[1,2-a]pyridine Derivatives, Pharmaceutical Compositions, And Methods Of Use As Beta-secretase Inhibitors App 20120101093 - Mjalli; Adnan M. M. ; et al.	2012-04-26
Azole Derivatives And Fused Bicyclic Azole Derivatives As Therapeutic Agents App 20120088778 - Mjalli; Adnan M.M. ; et al.	2012-04-12
Substituted Imidazo[1,2-b]pyridazine Derivatives, Pharmaceutical Compositions, And Methods Of Use As Beta-secretase Inhibitors App 20110237570 - Mjalli; Adnan M.M. ; et al.	2011-09-29
Phenyl-heteroaryl Derivatives And Methods Of Use Thereof App 20110230458 - Gohimukkula; Devi R. ; et al.	2011-09-22
Crystalline Forms Of [3-(4- -phenoxy)-propyl]-diethyl-amine App 20110166361 - Hari; Anitha	2011-07-07
Crystalline forms of [3-(4- {2-butyl- 1 -[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl- -amine Grant 7,884,219 - Hari February 8, 2	2011-02-08
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents App 20100256119 - Mjalli; Adnan M.M. ; et al.	2010-10-07
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents Grant 7,737,285 - Mjalli , et al. June 15, 2	2010-06-15
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents Grant 7,714,013 - Mjalli , et al. May 11, 2	2010-05-11
Crystalline Forms Of [3-(4- -phenoxy)-propyl]-diethyl-amine App 20080249316 - Hari; Anitha	2008-10-09
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents Grant 7,361,678 - Mjalli , et al. April 22, 2	2008-04-22
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents App 20070213347 - Mjalli; Adnan M. M. ; et al.	2007-09-13
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents App 20070021386 - Mjalli; Adnan M.M. ; et al.	2007-01-25
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents App 20040082542 - Mjalli, Adnan M.M. ; et al.	2004-04-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.